Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2021

Jun 5, 2021

32106_dirs_2021-06-04_1f155fa7-ae90-40f6-b1dc-5e0ff28237d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-04-21

Reporting Person: Hinson Andrew G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-21 Common Stock M 10714 $1.12 Acquired 20175 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-21 Employee Stock Option $1.12 M 10714 Disposed 2022-05-10 Common Stock (10714) Direct

Footnotes

F1: The number of securities reported in Column 5 is the number of securities beneficially owned as of June 4, 2021.